Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-21 Sale | 2020-08-24 6:21 pm | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer | 25,000 | $18.29 | $457,240 | 282,810 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-02-20 Tax Withholding | 2021-02-23 6:05 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer | 35,672 | $18.79 | 242,499 (Direct) | View |
| 2020-11-20 Tax Withholding | 2020-11-24 6:16 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer | 4,639 | $17.21 | 278,171 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director | 13,313 | $34.5 | 0 (Direct) | View |
| 2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director | 6,250 | $34.5 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director | 25,453 | $17.39 | 0 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 6:21 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer | 4,646 | $18.22 | 282,810 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 7:17 pm | N/A 2030-05-26 | Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director | 38,766 | $0 | 45,016 (Direct) | View |
| 2020-05-20 Tax Withholding | 2020-05-22 6:06 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc | 4,212 | $26.67 | 312,456 (Direct) | View |
| 2020-02-20 Tax Withholding | 2020-02-24 7:07 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc | 33,608 | $25.9 | 316,668 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 6:57 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc | 119,000 | $0 | 350,276 (Direct) | View |
| 2019-11-20 Tax Withholding | 2019-11-22 6:20 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc | 2,692 | $17.6 | 231,276 (Direct) | View |
| 2019-08-20 Tax Withholding | 2019-08-22 6:00 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc | 2,710 | $21.51 | 233,968 (Direct) | View |
| 2019-05-20 Tax Withholding | 2019-05-22 6:05 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc | 2,705 | $19.84 | 236,678 (Direct) | View |